antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.author | Meltzer, Maya Di | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponent | Megyeri, Attila | |
dc.contributor.opponentdept | University of Debrecen, Kenézy Gyula Campus Department of Anaesthesiology and Intensive Care | hu_HU |
dc.contributor.opponentdept | University of Debrecen, Department of Pharmacology and Pharmacotherapy | hu_HU |
dc.date.accessioned | 2021-05-16T07:11:10Z | |
dc.date.available | 2021-05-16T07:11:10Z | |
dc.date.created | 2021-03-08 | |
dc.description.abstract | This thesis offers a review of antiarrhythmic drugs with an emphasis on antiarrhythmic therapy during SARS-CoV-2 pandemic. Includes the general mechanisms causing arrhythmias with and without SARS-CoV-2 infection. in addition, drug-drug interactions between antiarrhythmics and drugs used in COVID-19 therapy are demonstrated, and the option of repurposing antiarrhythmic drugs for use against SARS-CoV-2 is discussed as well. to sum up, this is a comprehensive review of the pharmacological aspects of treating patients suffering from both rhythm abnormalities, and COVID-19. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | magyar | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 37 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/309663 | |
dc.language.iso | en | hu_HU |
dc.subject | antiarrhythmics | hu_HU |
dc.subject | SARS-CoV-2 | hu_HU |
dc.subject | COVID-19 | hu_HU |
dc.subject | drug interactions | hu_HU |
dc.subject.dspace | pharmacology | hu_HU |
dc.title | antiarrhythmic pharmacotherapy during SARS-COV-2 pandemic | hu_HU |